NEW YORK (360Dx) – Laboratory Corporation of America has completed its previously announced $1.2 billion cash acquisition of contract research organization Chiltern, which will become part of the company's Covance drug development business.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.